Atlas Trials

A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer

Clinical trial NCT01829841 · COMPLETED

Trial details

NCT number
NCT01829841
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell CancerMetastatic Renal Cell Cancer
Start date
2011-05-01
Primary completion
2013-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.